Varex Imaging Says Demand Steady Despite Geopolitics; Tariff Relief to Lift Margins, India Ramp Ahead

Core Viewpoint - Varex Imaging is experiencing stable demand despite geopolitical events and tariff volatility, with expectations for incremental margin improvement as prior tariff costs roll through inventory and long-term growth initiatives tied to manufacturing expansion in India and advancements in technology [6][12][18] Group 1: Demand and Market Conditions - Current conditions are described as "directionally positive," with ongoing policy discussions potentially leading to further changes [1] - Demand trends in security applications are at least "flat to positive," with increased inquiries about Varex's technologies [3] - The healthcare sector remains the largest end-market for Varex, driven by patient dynamics rather than macroeconomic events, with no significant impacts on hospital capital budgets reported [4] Group 2: Tariff and Pricing Adjustments - Varex has adjusted pricing and pass-through mechanisms in response to tariff escalations, with inventory levels affected by higher-tariff inventory still on hand [2] - If the current tariff regime remains, gross margin could improve modestly as older, higher-tariff inventory is cleared, with an estimated benefit of 30 to 50 basis points [7] Group 3: Regional Insights - In China, demand is stable to slightly growing, with a shift towards a more mature replacement-driven market, supported by government initiatives to enhance healthcare delivery in rural areas [8][9] - Domestic Chinese imaging players are gaining market share in competitive tenders, which is favorable for Varex as it supplies many of these players [10] Group 4: Growth Initiatives - Varex is ramping up production at two facilities in India, with expectations of generating approximately $100 million in incremental radiographic revenue over two years starting from fiscal 2027 [12][13] - The company is focused on photon-counting CT technology, aiming for deeper engagement with multiple OEMs by 2028 [14] Group 5: Financial Performance and Strategy - Recent debt refinancing has reduced coupon rates by about 175 basis points, resulting in annual interest savings of approximately $7 million to $8 million, translating to an annualized EPS benefit of about $0.15 to $0.16 [15] - The company aims to move corporate gross margin toward the high 30% range over the next few years, driven by growth in photon counting, cargo inspection systems, and India radiographic growth [18]